215 related articles for article (PubMed ID: 11964841)
1. Roles of prostaglandins and leukotrienes in acute inflammation caused by bacterial infection.
Yoshikai Y
Curr Opin Infect Dis; 2001 Jun; 14(3):257-63. PubMed ID: 11964841
[TBL] [Abstract][Full Text] [Related]
2. Arachidonic acid metabolites in hepatobiliary physiology and disease.
Kaminski DL
Gastroenterology; 1989 Sep; 97(3):781-92. PubMed ID: 2666254
[TBL] [Abstract][Full Text] [Related]
3. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
4. Eicosanoids, inflammation, and anti-inflammatory drugs.
Robinson DR
Clin Exp Rheumatol; 1989; 7 Suppl 3():S155-61. PubMed ID: 2691152
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandins, thromboxanes, and leukotrienes in inflammation.
Malmsten CL
Am J Med; 1986 Apr; 80(4B):11-7. PubMed ID: 2871754
[TBL] [Abstract][Full Text] [Related]
6. Interactions between leukotrienes and other inflammatory mediators/modulators in the microvasculature.
Hedqvist P; Gautam N; Lindbom L
Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S117-9. PubMed ID: 10673239
[No Abstract] [Full Text] [Related]
7. [Prostaglandins, thromboxanes and leukotrienes. Their role in cardiovascular diseases, allergic reactions and inflammation].
Maclouf J; Borgeat P; Grange MJ; Wautier JL; Caen JP
Presse Med; 1984 Jan; 13(2):91-6. PubMed ID: 6320156
[TBL] [Abstract][Full Text] [Related]
8. Vasodilatation and inhibition of mediator release represent two distinct mechanisms for prostaglandin modulation of acute mast cell-dependent inflammation.
Raud J
Br J Pharmacol; 1990 Mar; 99(3):449-54. PubMed ID: 2158843
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandins, thromboxanes, leukotrienes, and cytochrome P-450 metabolites of arachidonic acid.
Cook JA; Geisel J; Halushka PV; Reines HD
New Horiz; 1993 Feb; 1(1):60-9. PubMed ID: 7922394
[TBL] [Abstract][Full Text] [Related]
10. [Animal experiment studies on the role of inflammation mediators in corneal neovascularization].
Rochels R
Doc Ophthalmol; 1984 May; 57(3):215-62. PubMed ID: 6205837
[TBL] [Abstract][Full Text] [Related]
11. The arachidonic acid cascade. The prostaglandins, thromboxanes and leukotrienes.
Granström E
Inflammation; 1984 Jun; 8 Suppl():S15-25. PubMed ID: 6090312
[TBL] [Abstract][Full Text] [Related]
12. [Roles of lipid mediators in controlling vascular inflammation and the progression of atherosclerosis].
Endo J; Arita M
Nihon Rinsho; 2011 Jan; 69(1):34-8. PubMed ID: 21226257
[TBL] [Abstract][Full Text] [Related]
13. Role of prostaglandins in the cardiovascular effects of bradykinin and angiotensin-converting enzyme inhibitors.
Schrör K
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S68-73. PubMed ID: 1282633
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandins and leukotrienes.
Parker CW; Stenson WF
Curr Opin Immunol; 1989 Oct; 2(1):28-32. PubMed ID: 2514728
[No Abstract] [Full Text] [Related]
15. Prostaglandins, leukotrienes, phospholipase, platelet activating factor, and cytokines: an integrated approach to inflammation of human skin.
Greaves MW; Camp RD
Arch Dermatol Res; 1988; 280 Suppl():S33-41. PubMed ID: 2841909
[TBL] [Abstract][Full Text] [Related]
16. New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases.
Yacoubian S; Serhan CN
Nat Clin Pract Rheumatol; 2007 Oct; 3(10):570-9; quiz 1 p following 589. PubMed ID: 17906612
[TBL] [Abstract][Full Text] [Related]
17. Arachidonic acid metabolites: basic concepts relevant to plastic surgery.
Proctor KG; Shatkin S
J Reconstr Microsurg; 1988 Oct; 4(5):421-6. PubMed ID: 3143831
[TBL] [Abstract][Full Text] [Related]
18. Cardiac anaphylaxis: Part II: The role of prostaglandins, thromboxanes and leukotrienes in C.A.
Da Silva Machado FR; Assem ES; Ezeamuzie IC
Allergol Immunopathol (Madr); 1985; 13(4):335-50. PubMed ID: 2417469
[TBL] [Abstract][Full Text] [Related]
19. Leukotrienes and prostaglandins in asthma.
Bisgaard H
Allergy; 1984 Aug; 39(6):413-20. PubMed ID: 6208802
[TBL] [Abstract][Full Text] [Related]
20. Evidence for prostaglandins and leukotrienes as mediators of phase I of estrogen action in implantation in the mouse.
Gupta A; Huet YM; Dey SK
Endocrinology; 1989 Jan; 124(1):546-8. PubMed ID: 2491811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
